These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 7739505)
1. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Owens T; Sriram S Neurol Clin; 1995 Feb; 13(1):51-73. PubMed ID: 7739505 [TBL] [Abstract][Full Text] [Related]
2. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Martin R; McFarland HF Crit Rev Clin Lab Sci; 1995; 32(2):121-82. PubMed ID: 7598789 [TBL] [Abstract][Full Text] [Related]
3. Experimental allergic encephalomyelitis animal models for analyzing features of multiple sclerosis. Petry KG; Boullerne AI; Pousset F; Brochet B; Caillé JM; Dousset V Pathol Biol (Paris); 2000 Feb; 48(1):47-53. PubMed ID: 10729911 [TBL] [Abstract][Full Text] [Related]
4. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis. El Behi M; Dubucquoi S; Lefranc D; Zéphir H; De Seze J; Vermersch P; Prin L Immunol Lett; 2005 Jan; 96(1):11-26. PubMed ID: 15585303 [TBL] [Abstract][Full Text] [Related]
7. Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Sriram S; Steiner I Ann Neurol; 2005 Dec; 58(6):939-45. PubMed ID: 16315280 [TBL] [Abstract][Full Text] [Related]
8. Lessons from multiple sclerosis: models, concepts, observations. Wekerle H Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii56-60. PubMed ID: 19022815 [TBL] [Abstract][Full Text] [Related]
9. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets. Holmøy T Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322 [TBL] [Abstract][Full Text] [Related]
10. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis]. Rodríguez-Rodríguez Y; Suárez-Luis I Rev Neurol; 2003 Apr 1-15; 36(7):649-52. PubMed ID: 12666047 [TBL] [Abstract][Full Text] [Related]
11. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). Ziemssen T; Ziemssen F Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612 [TBL] [Abstract][Full Text] [Related]
12. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis. Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745 [TBL] [Abstract][Full Text] [Related]
14. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Olechowski CJ; Truong JJ; Kerr BJ Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337 [TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis: human model for EAE? Hohlfeld R Eur J Immunol; 2009 Aug; 39(8):2036-9. PubMed ID: 19672899 [TBL] [Abstract][Full Text] [Related]
16. Exacerbation of protracted-relapsing experimental allergic encephalomyelitis in DA rats by gluten-free diet. Di Marco R; Mangano K; Quattrocchi C; Amato F; Nicoletti F; Buschard K APMIS; 2004 Oct; 112(10):651-5. PubMed ID: 15601316 [TBL] [Abstract][Full Text] [Related]
17. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies. Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762 [TBL] [Abstract][Full Text] [Related]
19. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Steinman L; Zamvil SS Trends Immunol; 2005 Nov; 26(11):565-71. PubMed ID: 16153891 [TBL] [Abstract][Full Text] [Related]
20. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis. Miller SD; McMahon EJ; Schreiner B; Bailey SL Ann N Y Acad Sci; 2007 Apr; 1103():179-91. PubMed ID: 17376826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]